Learn More
About Orchestra
Orchestra Life Sciences is a technical consultancy. We provide strategic support and scientific expertise to advance pharmaceutical therapies for cancer and rare disease. Orchestra offers services instrumental to clients in nuclear medicine, radiation oncology, cell and gene therapies, regenerative medicines, and biotechnology. We work in concert with our clients to provide unparalleled expertise; speeding time to market.
Align
Our team of experts help clients align business strategies, regulatory approaches, engineering processes, and go-to-market plans.
Accelerate
We accelerate projects by streamlining supply chains, facilitating business relationships, and guiding regulatory compliance.
Achieve
We provide the right expertise at the right time to execute challenging projects, enable effective decision-making, and solve complex technical problems to achieve client goals.
Discover
Our Services
Orchestra’s team of consultants provide end-to-end expertise and support to bring commercial therapies to market
Find Out
Subject matter experts with more than 100 years of combined experience in novel therapies
Deep market knowledge and intelligence
Strategic relationships with key service providers, vendors, and suppliers
Proven track record of successful project execution
Radiopharmaceutical subject matter experts in nuclear
regulations, radiochemistry, process development, engineering, operations
Cell and gene therapy expertise in FDA regulations, process and analytical development, engineering, automation, and operations
Subject matter experts with more than 100 years of combined experience in novel therapies
Deep market knowledge and intelligence
Strategic relationships with key service providers, vendors, and suppliers
Radiopharmaceutical subject matter experts in nuclear
regulations, radiochemistry, process development, engineering, operations
Cell and gene therapy expertise in FDA regulations, process and analytical development, engineering, automation, and operations
Learn More
OUR CLIENTS
Orchestra serves clients on multiple continents in the disciplines of:
- Cell and Gene Therapy
- Biotechnology
- Radioligand Therapy
- Nuclear Medicine
- Radiation Oncology
- Fusion
Meet Our
Owners
Meet Our
Executives
James Daly
Vice President, Architectural & Design Engineering
Jessica Giffey
Vice President, Radiopharmaceutical Programs
Brian Kirk
Vice President, Construction
Sam Meer
Vice President, Strategy, Supply Chain & PMO
Meet Our
Advisors
Ralph Butler
Senior Advisor
Dale Simpson
Senior Advisor
Siddarth Agrawal
Strategic Advisor
Meet Our
Our Team
Sandra Boyd
Sr. Director,CQV
Zach Lewis
Sr. Director, Regulatory & Compliance
John schmitz
Sr. Director, Technical Operations
Ernie Banks
Director, Operational Excellence
Becky Cooper
Director, Quality Assurance & Compliance
Clement Cheung
Director, Process Chemistry & Engineering
Al Edinger
Director, Field Operations
Stephen Mansker
Director, Manufacturing Operations
Hiten Patel
Director, Manufacturing Operations
Nicholas Baldasaro
Project Director
Taylor Clark
Project Director
Ian Moy
Project Director
Keith Thompson
Sr. Technical Program Manager
Jack Bauers
Technical Program Manager
Cristian Boas
Sr. Radiochemist
Timo Henk
Sr. Process Engineer
Ellen Ryan
Sr. Process Engineer
Sterling Marshall
Quality Engineer and Instrumentation
Eriselda Leka
Quality Engineer
Bruna Teixeira
Quality Engineer
Savani Nagarkar
Project Engineer
Stephanie Bladdick
Project Manager
Marie-Michelle Coulombe
Project Manager
Lakeisha Green
Project Manager
Robert Matteoni
Project Manager
Greg Bushman
Sr. Consultant, Radiopharmaceutical Manufacturing
Cole Ashlock
Radioisotope SME
Mo Meer
Manager, Software Engineering
Erin Maniscalco
Design Engineer
Be Up To Date
Execution Considerations as Europe’s Radiopharmaceutical Ecosystem Scales
In advanced therapies, outcomes are rarely determined at the point of delivery, they are set much earlier, by decisions teams don’t always recognize. At Orchestra

Execution Is The Contraint: Why Infrastrucure Now Defines Success In Advanced Therapies
Execution as a Design Problem in Advanced Therapies Advanced therapies are being shaped by constraints that sit outside the lab. Scientific progress continues, but outcomes

How Advanced Therapies and Radiopharmaceuticals Redefined the Future of Drug Development
Orchestra Life Sciences’ Year-End Perspectives The life sciences sector entered 2025 with considerable momentum and concluded the year having experienced meaningful scientific, regulatory, and operational

Orchestra Life Sciences Expands into Europe to Support Radiopharmaceutical Execution, Appoints Vinod Ramnandanlal as President and Managing Director
The expansion builds on existing client engagements and growing demand for regional execution support. The expansion builds on existing client engagements and growing demand for
Orchestra Life Sciences Relocates Global Headquarters to Philadelphia’s Navy Yard
Relocation reflects Orchestra’s commitment to innovation, ecosystem growth, and building the advancedtherapy workforce of the future Philadelphia, PA, October 22, 2025 — Orchestra Life Sciences

BioCentriq Partners with Orchestra Life Sciences to Advance Princeton, NJ Cell TherapyFacility Development
Princeton, NJ, January 14– BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a strategic partnership with Orchestra Life Sciences (OLS),
Feel Free To